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doi:10.1Objective: In-hospital cardiac arrest or refractory shock carries a high mortality despite the use of advanced
resuscitative measures. We have implemented an in-hospital, nurse-based, continuously available, percutaneous,
venoarterial cardiopulmonary bypass system, also known as extracorporeal life support (ECLS), as an adjunct to
resuscitation when initial measures are ineffective.
Methods: In 1986, a system for the rapid initiation of ECLS, was created inwhich trained critical care nurses primed
an ECLS circuit and in-house physicians percutaneously placed required cannulas. From a prospective registry, we
assessed long-term survival (LTS) (30 days, cardiopulmonary support weaned), short-term survival (<30 days,
CPS weaned), or death on CPS.
Results: One hundred fifty patients (age, 57 17 years) were urgently started on CPS for cardiac arrest (n¼ 127;
witnessed, n¼ 124; unwitnessed, n¼ 3) and refractory shock (n¼ 23). Sixty-nine patients were weaned fromCPS,
and 81 could not be weaned. Overall, 39 (26.0%) patients achieved LTS with a subsequent Kaplan–Meier median
survival of 9.5 years. Duration of CPS was 32 38 hours for LTS and 21 38 hours for non-LTS. LTS occurred
in 29 (23.4%) of 124 patients started on CPS for witnessed cardiac arrest and 11 (47.8%) of 23 for refractory shock
(P<.05). Among patients with CPS initiated in the cardiac catheterization laboratory, LTS was seen in 24 (50.0%)
of 48 versus 15 (14.7%) of 102 in patients with CPS initiated in other locations (P< .001). Cardiopulmonary re-
suscitation times greater than or equal to 30 minutes were associated with lower LTS (P<.05). The most common
cause of death duringCPSwas refractory cardiac dysfunction (39.5%), and themost common cause associatedwith
short-term survival was neurologic/pulmonary dysfunction (53.6%). Seven patients were bridged to a left ventric-
ular assist device, and 1 subsequently underwent heart transplantation. Multivariate analysis revealed only cardiac
catheterization laboratory site of initiation as a significant independent predictor of LTS (P<.01).Whendividing the
20-year experience in tertiles, recent recipients have had more common prearrest insertion. Rates of long-term sur-
vival have not changed.
Conclusion: Of patients started on CPS, 46% were weaned, and 26.0% were long-time survivors. Rapid initi-
ation of CPS permits LTS for some inpatients with cardiovascular collapse when initial advanced resuscitation
fails. Strategies to improve end-organ function associated with use of CPS should lead to greater LTS. This prac-
tical application of inexpensive available technology should be more widely used. (J Thorac Cardiovasc Surg
2010;139:753-7)Supplemental material is available online.
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Xrefractory shock or cardiac arrest still demonstrate dismal
rates of long-term survival. Using standardized criteria,1
a recent multicenter study in the United States found a sur-
vival to discharge after adult in-hospital cardiac arrest of
17%.2 In patients who require more than 10 minutes of
CPR, a 30-day survival of 15.0% has been reported in a sin-
gle-center report.3
In 1954,Gibbon4 reported the development of a cardiopul-
monary bypass system that allowed surgeons to perform
complex cardiac repairs for the first time. In 1985, a portable
cardiopulmonary support (CPS) system was developed
(C. R. Bard, Inc, Billerica, Mass) that could be used with
percutaneous catheters, making it possible to implement
cardiopulmonary bypass outside the operating room without
opening the chest.4 The extracorporeal system was designed
for rapid implementation in patients who would otherwise
not survive with refractory cardiac or respiratory failure.rdiovascular Surgery c Volume 139, Number 3 753
Abbreviations and Acronyms
CNS ¼ central nervous system
CPR ¼ cardiopulmonary resuscitation
CPS ¼ cardiopulmonary support
LTS ¼ long-term survivor
PEA ¼ pulseless electrical activity
VT/VF ¼ ventricular tachycardia/ventricular
fibrillation
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XThese techniques have been referred to as extracorporeal life
support,3,5 extracorporeal membrane oxygenation,6,7 or car-
diopulmonary bypass support.8,9
In principle, prompt application of CPS could rescue pa-
tients with cardiovascular collapse, especially if reversible
causes are present10,11 and neurologic function is preserved.12
In practice, however,widespread application has been limited.
In 1986, we began a program with a prospective registry
of nurse-supported physician initiation of percutaneous CPS
that did not initially require a perfusionist. This report
reviews our experience with the urgent use of CPS in 150
patients over a 20-year period.MATERIALS AND METHODS
This review of patients started on emergency portable CPS at Sharp
Memorial Hospital between June 1986 and December 2008 was approved
by the Investigational Review Board at Sharp Healthcare.
Patients were selected by the resuscitating physician for emergency CPS
when cardiac arrest persisted despite initial advanced cardiac life support or
for treatment of refractory shock with imminent cardiac arrest. Patients with
CPS support for elective percutaneous cardiac intervention, after a cardiot-
omy and after failure to wean from conventional bypass, or transferred to
our institution after initiation elsewhere were excluded.
Initiation of CPS was accomplished by means of either percutaneous or
cut-down placement of cannulas in the femoral or jugular vein (18F–20F)
and femoral artery (16F–18F) by using methods previously described.13 If
femoral artery cannulationwas associatedwith distal limb ischemia, then an-
tegrade perfusionwas initiated by usingmethods previously described.14 Pa-
tients undergoing recent cardiac surgery had cannulas placed in central
vessels after urgent bedside sternotomy. Treatment was with a BARD (C.
R. Bard, Inc, Murrayhill, NJ) hollow-fiber oxygenator in patients 1 to 57
and a heparin-bonded oxygenator (Maxima or Affinity; Medtronic, Minne-
apolis,Minn) in patients 58 to 150.ABiomedicus (Medtronic, Anaheim, Ca-
lif; see Figure E1) centrifugal pump was used in all cases. Before the use of
heparin-bonded oxygenators and circuits, activated clotting time was main-
tained at approximately 300 seconds. With a heparin-bonded oxygenator
and circuit, heparin was titrated to an activated clotting time of between
150 and 180 seconds or 120 and 150 seconds if bleeding ensued. Radio-
graphic fluoroscopic guidance was used if immediately available.
Critical care nurses trained in initiation of emergency CPS were respon-
sible for initiation of flow after priming a preassembled centrifugal pump
and oxygenator circuit with Isolyte S electrolyte solution (Braun Medical,
Irvine, Calif), which is composed of sodium chloride, sodium gluconate, so-
dium acetate trihydrate, potassium chloride, and magnesium chloride hexa-
hydrate. When cannulation was complete, bypass tubing was connected to
the arterial and venous cannulas, and flow was optimized by adjusting the
centrifugal pump rotation rate.754 The Journal of Thoracic and Cardiovascular SurgSurgical or percutaneous interventions were undertaken if the patient
appeared to have a survivable illness and if a remediable cause for cardiac
arrest was present. Support was continued until a definitive corrective
procedure could be performed, the patient died during bypass, or cardiovas-
cular stabilization permitted weaning from CPS. When possible, weaning
from CPS was attempted with gradual reduction of pump flow if mean
arterial pressure remained greater than 60 mm Hg on low-dose inotropic
support. Most patients required transfusion of packed erythrocytes shortly
after initiation of CPS.
Clinical Data
The national mortality database was queried to obtain long-term dates of
death. Demographic information, preclinical conditions, support type, and
cause of death were recorded in a prospective registry. Time of CPS initia-
tion was considered routine if between 9 AM and 5 PM Monday through
Friday and off hours otherwise. Cardiac rhythms at the time of cardiac arrest
and refractory shock were reviewed from computerized hospital records
available from the last 8 years. Cardiac causes were specified as coronary
(with a history of coronary artery disease), noncoronary, or unknown car-
diac. Other causes were specified as either noncardiac or unknown.
Statistical Analysis
Results are expressed as the mean  standard deviation. Comparisons
were made with a 2-tailed Student t test for continuous variables and
Pearson’s c2 analysis for categoric data. Multivariate logistic regression
was performed for long-term survival with SPSS software using variables
of sex, age, cause of initiation, time of day, cause of cardiovascular collapse,
and location of CPS initiation. From this, a C (convergence) statistic was
derived from a receiver operating characteristic curve analysis to assess
the predictive accuracy of the regression model. Kaplan–Meier analysis
for time to death from the date of long-term survival (30 days after
initiation) was performed.RESULTS
One hundred-fifty patients (103 male and 47 female
patients) aged 57  17 years were started on emergency
CPS. CPS was initiated for cardiac arrest in 127 patients
(124 witnessed and 3 unwitnessed) and refractory shock in
23 patients (including 2 after defibrillation for ventricular
fibrillation without CPR). Cannulation was percutaneous
in 94, cut-down in 16, open-chest in 30 (after recent cardiac
surgery), and not reported in 10 patients (Table 1). Causes of
cardiovascular collapse are shown in Table 2.
Overall, 39 (26.0%) patients were long-term survivors
(LTS; alive 30 days with successful weaning), 30
(20.0%) patients were short-term survivors (alive <30
days with successful weaning), and 81 (54%) patients
died on CPS (Figure 1). Long-term survivors had a subse-
quent Kaplan–Meier median survival of 9.5 years (Figure 2).
In patients who were successfully weaned from CPS, 39
(59.4%) of 69 were LTS. Duration of CPS support was 32
 38 hours for LTS and 21  38 hours for non-LTSs.
Eleven (47.8%) patients with refractory shock and 29
(23.4%) patients with witnessed cardiac arrest were LTS
(P<.05, see Figure E2). Three patients with an unwitnessed
cardiac arrest died on CPS.
Of 67 patients with available rhythms during cardiac
arrest, 45 (67.2%) had pulseless electrical activity (PEA),ery c March 2010
TABLE 1. Demographics for 150 patients started on emergency
cardiopulmonary support over the past 20 years
Age (y) 57  17
Support time (h) 24.3  38.6
Sex
Male 103
Female 47
Indication for extracorporeal life support
Cardiac arrest 127
Refractory shock 23
Cannulation
Peripheral, percutaneous 94
Peripheral, cut-down 16
Open-chest 30
Unspecified 10
Oxygenator
BARD-HF 4000 56
Heparin-bonded Maxima 55
Heparin-bonded Affinity 39
FIGURE1. Distribution of patient survival durations.Alive<30d,Weaned
from cardiopulmonary support but not long-term survivors; expired, death
on cardiopulmonary support.
Jaski et al Cardiothoracic Transplantation14 (20.9%) had ventricular tachycardia/ventricular
fibrillation (VT/VF), and 8 (11.9%) had asystole. Twelve
(26.7%) patients with PEA, 6 (42.9%) patients with VT/
VF, and 1 (12.5%) patient with asystole were LTS
(P ¼ .31).
CPR times of 30 minutes or longer were associated with
lower long-term survival rates (see Figure E3, P< .05).
Reasons for prolongation of CPR beyond 30 minutes
included intermittent need for CPR, delay in decision
making regarding need for CPS, and difficulty in achieving
cannulation.
In patients with CPS initiated in the cardiac catheteriza-
tion laboratory, long-term survival was seen in 24 (50.0%)
of 48 versus 15 (14.7%) of 102 with CPS initiated elsewhere
than the cardiac catheterization laboratory (critical care unit
and other; P< .001). In the cardiac catheterization labora-
tory indication for CPS showed a trend to have an effect
on long-term survival. No difference in CPR times in
patients undergoing arrest in the cardiac catheterization
laboratory versus other locations was observed (Figure 3).
Seventeen (45.9%) of 37 patients with cardiac arrest versus
7 (63.6%) of 11 patients with refractory shock who had CPSTABLE 2. Prearrest cause
Cause Total Patients achieving LTS % LTS
Cardiac 113 34 31
Coronary cardiac 86 27 31
Noncoronary cardiac 20* 7 35
Unknown cardiac 7 0 0
Noncardiac 32y 4 12.5
Unknown 5 1 20
Total 150 39 26
LTS, Long-term survival *Cardiomyopathy (n¼ 8), transplant rejection (n¼ 6), myo-
carditis (n¼ 2), and ‘‘other’’ (n¼ 4) yPulmonary embolus (n¼ 6), amniotic fluid em-
bolism (n ¼ 4), aortic disease (n ¼ 3), septic shock (n ¼ 2), and ‘‘other’’ (n ¼ 17).
The Journal of Thoracic and Cainitiated in the cardiac catheterization laboratory were LTS
(P ¼ .77).
In those who died during CPS, the cause of death was
persistent cardiac dysfunction in 32 (39.5%) of 81 patients,
whereas 23 (28.4%) patients died of central nervous system
(CNS)/pulmonary complications. Fifteen (50.0%) of 30
patients who were short-term survivors (after CPS weaning)
died of CNS/pulmonary causes, whereas 6 (20.0%) patients
died of persistent cardiac dysfunction (P ¼ .066, cardiac vs
CNS/pulmonary vs other).
CPS initiation time of day was available for 129 of 150
patients. Seventeen (32.1%) of 53 patients who had CPS
initiated between Monday through Friday from 9 AM to 5
PM were LTS compared with 18 (24.0%) of 76 outside of
these times. CPS led to left ventricular assist device implan-
tation in 7 (4.7%) patients and subsequent cardiac transplan-
tation in 1 (0.7%) of these patients. When dividing the
20-year experience in tertiles, recent recipients have had
more common prearrest insertion (see Figure E4). Rates of
long-term survival have not changed over time.FIGURE 2. Kaplan–Meier survival in patients surviving 30 days. T½,
Median survival.
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FIGURE 3. Survival by location of in-hospital cardiopulmonary support
(CPS) insertion.
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XMultivariate logistic regression of long-term survival was
conducted by using variables of sex, indication for CPS
initiation (refractory shock vs cardiac arrest), age, CPR
time, location of CPS initiation, cause of cardiovascular
collapse, and time of day. Of these values, only location of
CPS initiation was found to be an independent variable
predictive of outcome (P< .01, see Table E1). Overall,
the regression model demonstrated a C statistic of 0.751,
indicating a modest value of predictive accuracy.DISCUSSION
To our knowledge, this single-center report represents the
largest series of consecutive cases of emergency use of CPS
for cardiovascular resuscitation of patients refractory to
conventional measures. Specifically excluded were patients
in whom CPS was initiated for elective-procedure support,
those with postcardiotomy failure to be weaned from bypass,
and those transferred from an outside hospital. Overall,
26.0% of patients started on CPS were LTS, with a subse-
quent median survival of 9.5 years. We found the long-
term survival rates for refractory shock versus witnessed car-
diac arrest to be 47.8% and 23.4%, respectively.Indication for CPS
When applied for refractory shock, Combes and
colleagues7 reported a CPS-associated 28-day survival rate
of 48%. In patients with persistent cardiac arrest, Chen
and associates3 retrospectively compared outcomes in
patients with longer than 10 minutes of conventional CPR
who subsequently underwent either CPS (n¼ 59) or contin-
ued conventional CPR (n ¼ 113). Using a propensity score
to match potential prognostic factors, there was a significant
difference in 30-day survival (hazard ratio, 0.47; 95%
confidence interval, 0.28–0.77; P ¼ .003) and 1-year
survival (hazard ratio, 0.53; 95% confidence interval,
0.33–0.83; P< .006),7 favoring extracorporeal CPS over
conventional CPR. CPS 30-day survival was 33.9%, and
1-year survival was 18.6%.3 Thus CPS is associated with756 The Journal of Thoracic and Cardiovascular Surgabout a 25% long-term survival. Fifty percent of those
weaned from CPS are alive 30 days after initiation of
support.
Multiple factors could contribute to improved outcomes
in the cardiac catheterization laboratory. The cardiac
catheterization laboratory environment provides fluoros-
copy and availability of adjunctive support equipment.
Physician and support staff are present. Alternatively, the
cardiac catheterization laboratory site could be a marker
for patients with reversible pathologies or better prognoses.
There might be less reluctance to initiate CPS support earlier
on the part of the physician given the above considerations.
No difference in CPR times in patients undergoing arrest in
the cardiac catheterization laboratory versus other locations
was observed. In a recent report from a multicenter registry
of CPS applied for cardiovascular collapse, survival to
hospital discharge was 27%. Although initiation of support
was not specified, percutaneous cannulation technique was
one of the several independent variables predicting survival
in a multivariate analysis.15
It is uncertain how to replicate outcomes in the cardiac
catheterization laboratory for patients in critical care units
or other environments. CPS placement could be initiated
sooner in patients with rapidly progressive shock before
cardiac arrest. Alternatively, patients could be either
transported to a cardiac catheterization laboratory environ-
ment, or crucial aspects of the cardiac catheterization labora-
tory environment could be replicated in intensive care units.
Our data suggest that the likelihood for long-term survival
with cardiac arrest might be influenced by the associated
cardiac rhythmduring a cardiac arrest. Although only a trend,
patients with VT/VF had long-term survival of 42.9% ver-
sus 25% in patients with PEA and 12.5% in patients with
asystole. In animal models of ventricular fibrillation, appli-
cation of CPS improves the subsequent likelihood of cardi-
oversion and survival compared with continued precordial
compression and external defibrillation.16,17 A recent report
in 11 patients found that CPS permitted termination of pre-
viously refractory ventricular tachycardia.18
In the event of cardiac arrest requiring CPR, the decision
to use CPS must be prompt because survival is unlikely
when CPR extends beyond 30 minutes. Factors that influ-
ence the decision to institute CPS should include whether
the patient has a remediable underlying disease process.
Previous studies support a strategy of CPS as a bridge to im-
plantable left ventricular assist device or heart transplanta-
tion in adult patients.11,19,20 However, only a small portion
of our patient population was bridged to other forms of
cardiac replacement.
Cause of Death
In general, after CPS, subsequent death from cardiac causes
implies an initial irreversible cardiovascular pathology associ-
ated with cardiovascular collapse, whereas death of CNS/ery c March 2010
Jaski et al Cardiothoracic Transplantationpulmonary causes suggests that CPSwas either insufficient or
delayed to maintain extracardiac oxygenated blood flow to
vital organs. Thus it is not surprising that the primary cause
of death in patients who were not weaned from CPS was
cardiac. In contrast, among patients who were successfully
weaned but were not LTS, cardiac complications were over-
come, but neurologic/pulmonary complications were not.
LIMITATIONS
Conclusions regarding the efficacy of CPS for emergency
resuscitation in our series are limited by the lack of a control
group. As noted above, although a case–control series with
matched patients from a cardiac arrest registry has been
reported,3 a randomized trial would be difficult to achieve.
As instrumentation and techniques continue to evolve,
registry data might have to suffice for evaluation of the
efficacy of CPS for cardiovascular collapse. A uniform
patient selection criterion for initiating CPS was not prespe-
cified in this series; however, this allowed assessment in
a range of patients more diverse than previous studies. This
is a single-center study that cannot be replicated in all centers;
it still represents the largest series reported to date. Detailed
complication-related data were not acquired for this registry.
IMPLICATIONS FOR FUTURE IMPROVEMENTS
Rapid application of CPS can temporarily support patients
with cardiovascular collapse and permit an assessment of
potential options for long-term survival. Before initiation,
the likelihood of long-term survival should be considered
based on the reversibility of the cause of collapse, the
expected duration of CPR, and patient location within
the hospital. Translating the results of CPS resuscitation in
the cardiac catheterization laboratory to other hospital envi-
ronments could further improve outcomes for the still-chal-
lenging condition of cardiovascular collapse.References
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FIGURE E1. Cardiopulmonary support cart.
FIGURE E3. Outcomes ofcardiopulmonary resuscitation (CPR) time.
CPS, Cardiopulmonary support.
FIGURE E4. Prearrest insertion rate.FIGURE E2. Cause of initiation of cardiopulmonary support (CPS).
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TABLE E1. Multivariate analysis
Variables
Dummy-coded
vectors B SE P value OR 95% CI
Location .007
Critical care unit 1.36 0.50 .007 3.90 1.45–10.44
ED/floor/other 2.37 0.92 .010 10.65 1.76–64.27
Sex 0.25 0.49 .600 0.78 0.30–2.01
Arrest 0.24 1.55 .877 1.27 0.06–26.46
CPR time .588
CPR 29 min 0.21 1.49 .887 1.24 0.07–22.81
CPR 30 min 0.49 1.53 .751 1.63 0.08–32.70
Unknown 0.51 1.64 .755 0.60 0.02–14.96
Age 0.02 0.01 .304 1.02 0.99–1.04
Time/day for
implantation
.792
Weekday (9 AM-5 PM) 0.28 0.50 .579 1.32 0.50–3.47
Unknown 0.12 0.65 .849 0.88 0.25–3.16
Cause .655
Cardiac noncoronary 0.09 0.68 .891 0.91 0.24–3.47
Cardiac unknown 1.45 1.31 .270 4.25 0.33–55.66
Noncardiac 0.64 0.69 .355 1.89 0.49–7.32
Unknown 0.60 1.40 .669 0.55 0.04–8.56
Note: For dummy-coded vectors, the reference groups are as follows (in bold): location (cardiac catheterization laboratory); CPR time (no CPR); time/day for implantation
(weekend or 5 PM to 9 AM); and cause (cardiac coronary). B, Logit; SE, standard error; OR, odds ratio; CI, confidence interval.
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